Organogenesis Holdings Inc (ORGO) — Cash Flow Quality Index
Organogenesis Holdings Inc (ORGO) has a Cash Flow Quality Index of 0.14x as of September 2025. Operating cash flow of $3.08 Million is below net income of $21.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Organogenesis Holdings Inc (ORGO) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Organogenesis Holdings Inc Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Organogenesis Holdings Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Organogenesis Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Organogenesis Holdings Inc (2020–2024)
Year-by-year earnings quality comparison for Organogenesis Holdings Inc. For live market cap and the full company financial profile, see Organogenesis Holdings Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 16.50x | $14.21 Million | $861.00K | ▲ +163.9% |
| 2023 | 6.25x | $30.92 Million | $4.95 Million | ▲ +290.6% |
| 2022 | 1.60x | $24.86 Million | $15.53 Million | ▲ +145.1% |
| 2021 | 0.65x | $61.98 Million | $94.90 Million | ▲ +105.9% |
| 2020 | 0.32x | $5.47 Million | $17.23 Million | — |